Ramius Advisors’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Ramius Advisors’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-78,356	Closed	-$1.89M	–	67
2023 Q1	$1.89M	Buy	+78,356	New	+$983K	1.98%	14

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Ramius Advisors's PRVB Position: Q2 2023 in Review

Ramius Advisors sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 78,356 shares — an estimated $1.89M sold.

Ramius Advisors first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $1.89M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Ramius Advisors reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Ramius Advisors sold 78,356 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $1.89M.
Ramius Advisors first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Ramius Advisors's Provention Bio, Inc. Common Stock position peaked at $1.89M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Ramius Advisors's 13F filing for Q2 2023.